Drug Profile
Cancer vaccine - ImmunoFrontier
Alternative Names: CHP-MAGE-A4 - ImmunoFrontier; CHP-MAGE-A4 cancer vaccine - ImmunoFrontierLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator ImmunoFrontier
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Cancer in Japan (Parenteral)